Retirement Systems of Alabama Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

Retirement Systems of Alabama decreased its holdings in DaVita Inc. (NYSE:DVA) by 2.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,870 shares of the company’s stock after selling 305 shares during the period. Retirement Systems of Alabama’s holdings in DaVita were worth $1,244,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of DVA. Vanguard Group Inc. boosted its holdings in DaVita by 1.1% in the third quarter. Vanguard Group Inc. now owns 6,175,029 shares of the company’s stock worth $583,725,000 after purchasing an additional 65,526 shares during the last quarter. Invesco Ltd. lifted its holdings in DaVita by 21.3% in the third quarter. Invesco Ltd. now owns 1,667,255 shares of the company’s stock valued at $157,606,000 after acquiring an additional 292,767 shares during the period. Deutsche Bank AG increased its position in shares of DaVita by 421.8% during the 3rd quarter. Deutsche Bank AG now owns 1,095,081 shares of the company’s stock valued at $103,518,000 after purchasing an additional 885,195 shares during the last quarter. Lazard Asset Management LLC boosted its holdings in shares of DaVita by 8.7% in the third quarter. Lazard Asset Management LLC now owns 845,416 shares of the company’s stock worth $79,916,000 after buying an additional 67,970 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in DaVita by 15.7% during the third quarter. Northern Trust Corp now owns 834,608 shares of the company’s stock valued at $78,895,000 after buying an additional 113,508 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DaVita

In other DaVita news, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now directly owns 20,264 shares in the company, valued at approximately $2,424,384.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now directly owns 488,697 shares of the company’s stock, valued at $61,629,578.67. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider James O. Hearty sold 26,164 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the transaction, the insider now directly owns 20,264 shares of the company’s stock, valued at $2,424,384.96. The disclosure for this sale can be found here. Insiders sold 134,540 shares of company stock worth $16,551,071 over the last 90 days. Company insiders own 1.40% of the company’s stock.

DaVita Stock Performance

DaVita stock opened at $135.84 on Thursday. The company has a market cap of $11.91 billion, a PE ratio of 15.44, a price-to-earnings-growth ratio of 1.17 and a beta of 1.04. DaVita Inc. has a twelve month low of $71.51 and a twelve month high of $145.04. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95. The company’s 50-day moving average price is $134.33 and its 200-day moving average price is $114.05.

DaVita (NYSE:DVA) last released its earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The firm had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.03 billion. During the same quarter in the previous year, the company posted $1.58 EPS. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. On average, equities research analysts forecast that DaVita Inc. will post 9.49 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DVA has been the subject of several recent research reports. Truist Financial boosted their price target on DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a report on Tuesday, February 20th. StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Monday. Barclays raised their price target on DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a report on Monday. UBS Group lifted their target price on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Finally, TheStreet upgraded shares of DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $121.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.